These tests have recognized limitations in clinical practice, such as low sensitivity, lengthy delay, or invasiveness [3, 4]; as a result, multiple biomarkers in pleural effusion have been investigated, including adenosine deaminase (ADA) and interferon-gamma (IFN-γ) [5]. Here, ADA is linked to Pleural effusion.